News | 14 August 2012
Puma Biotechnology, Inc. (OTCBB: PBYI), a development stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2012. For the quarter ended June 30, 2012, Puma reported a net loss applicable to ...
Click on the link to read the full article at 4-traders
(This link will open in a new window)